why is compounded tirzepatide banned Troubling Findings in Study of GLP-1 Compounders Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

Even with a gradual biosimilar uptake post-2028, Merck faces a multi-billion dollar revenue challenge that requires successful pipeline advancement in oncology, vaccines, and cardiometabolic disease to maintain long-term earnings growth

Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study

In 2024, it was also approved to treat moderate to severe OSA in adults with obesity, and to be used along with a reduced calorie diet and increased physical activity

Clinical trials demonstrate that the co-administration of cagrilintide with semaglutide leads to significant reductions in HbA1c and body weight, highlighting their combined efficacy in managing obesity and metabolic disorders